Synthesis, in vitro antiviral evaluation, and stability studies of bis(S-acyl-2-thioethyl) ester derivatives of 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA) as potential PMEA prodrugs with improved oral bioavailability. 1996

S Benzaria, and H Pélicano, and R Johnson, and G Maury, and J L Imbach, and A M Aubertin, and G Obert, and G Gosselin
Laboratoire de Chimie Bioorganique, UMR CNRS-USTL, Université Montpellier II, France.

A new series of hitherto unknown 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA) phosphonodiester derivatives incorporating carboxyesterase-labile S-acyl-2-thioethyl (SATE) moieties as transient phosphonate-protecting groups was prepared in an attempt to increase the oral bioavailability of the antiviral agent PMEA. We report here a direct comparison of the in vitro anti-HIV and anti-HSV activities as well as the in vitro stability between the bis(SATE) derivatives and the already known PMEA prodrugs, namely, bis[(pivaloyloxy)methyl (POM)]- and bis[dithiodiethyl (DTE)]PMEA. All of the compounds tested showed an enhanced in vitro antiviral activity compared to the parent PMEA. The bis(POM)- and bis(tBu-SATE)PMEA derivatives were the most effective. However, striking differences between these two compounds were found during the stability studies. In particular the bis(tBu-SATE)PMEA was found to be more stable than bis(POM)PMEA in human gastric juice and human serum, suggesting it could be considered as a promising candidate for further in vivo development.

UI MeSH Term Description Entries
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000225 Adenine A purine base and a fundamental unit of ADENINE NUCLEOTIDES. Vitamin B 4,4, Vitamin B,B 4, Vitamin
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D016339 Spectrometry, Mass, Fast Atom Bombardment A mass spectrometric technique that is used for the analysis of a wide range of biomolecules, such as glycoalkaloids, glycoproteins, polysaccharides, and peptides. Positive and negative fast atom bombardment spectra are recorded on a mass spectrometer fitted with an atom gun with xenon as the customary beam. The mass spectra obtained contain molecular weight recognition as well as sequence information. Fast Atom Bombardment Mass Spectrometry,Fast Atom Bombardment Mass Spectroscopy,Mass Spectrometry, Fast Atom Bombardment,Mass Spectroscopy, Fast Atom Bombardment,Spectroscopy, Mass, Fast Atom Bombardment

Related Publications

S Benzaria, and H Pélicano, and R Johnson, and G Maury, and J L Imbach, and A M Aubertin, and G Obert, and G Gosselin
June 1994, Journal of medicinal chemistry,
S Benzaria, and H Pélicano, and R Johnson, and G Maury, and J L Imbach, and A M Aubertin, and G Obert, and G Gosselin
January 2007, Bioorganic & medicinal chemistry letters,
S Benzaria, and H Pélicano, and R Johnson, and G Maury, and J L Imbach, and A M Aubertin, and G Obert, and G Gosselin
December 2006, Journal of medicinal chemistry,
S Benzaria, and H Pélicano, and R Johnson, and G Maury, and J L Imbach, and A M Aubertin, and G Obert, and G Gosselin
January 2005, Nucleosides, nucleotides & nucleic acids,
S Benzaria, and H Pélicano, and R Johnson, and G Maury, and J L Imbach, and A M Aubertin, and G Obert, and G Gosselin
October 2003, Journal of medicinal chemistry,
S Benzaria, and H Pélicano, and R Johnson, and G Maury, and J L Imbach, and A M Aubertin, and G Obert, and G Gosselin
November 2000, Journal of medicinal chemistry,
S Benzaria, and H Pélicano, and R Johnson, and G Maury, and J L Imbach, and A M Aubertin, and G Obert, and G Gosselin
December 2004, Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry,
S Benzaria, and H Pélicano, and R Johnson, and G Maury, and J L Imbach, and A M Aubertin, and G Obert, and G Gosselin
January 2000, Metal-based drugs,
S Benzaria, and H Pélicano, and R Johnson, and G Maury, and J L Imbach, and A M Aubertin, and G Obert, and G Gosselin
February 2003, Journal of medicinal chemistry,
S Benzaria, and H Pélicano, and R Johnson, and G Maury, and J L Imbach, and A M Aubertin, and G Obert, and G Gosselin
August 2015, ChemMedChem,
Copied contents to your clipboard!